ライフサイエンスコーパス: randomized, double-blind, placebo-controlled trial

1 We conducted a phase 2, randomized, double-blind, placebo-controlled trial in 27 cent

2 This PreSERVE-AMI (Phase 2, randomized, double-blind, placebo-controlled trial) represent

3 In this phase 2, randomized, double-blind, placebo-controlled trial, we compar

4 Phase 3, randomized, double-blind, placebo-controlled trial conducted

5 We conducted a phase 3, randomized, double-blind, placebo-controlled trial of a month

6 A phase 3, randomized, double-blind, placebo-controlled trial was perfor

7 A randomized, double-blind, placebo-controlled trial (Effects o

8 A randomized, double-blind, placebo-controlled trial was perfor

9 We performed our study as a randomized, double-blind, placebo-controlled trial by trainin

10 We conducted a randomized, double-blind, placebo-controlled trial involving

11 We conducted a randomized, double-blind, placebo-controlled trial involving

12 We conducted a randomized, double-blind, placebo-controlled trial of amitrip

13 We conducted a randomized, double-blind, placebo-controlled trial of pregaba

14 In a randomized, double-blind, placebo-controlled trial (the Dieta

15 oral acyclovir reduces the incidence of herpes zoster in a randomized, double-blind, placebo-controlled trial among 3408

16 e-nucleotide polymorphisms (SNPs) in 2259 participants in a randomized, double-blind, placebo-controlled trial conducted

17 In a randomized, double-blind, placebo-controlled trial conducted

18 at baseline and 24-week intervals in a substudy of iPrEx, a randomized, double-blind, placebo-controlled trial of FTC/TDF

19 The Vitamin D Assessment Study is a randomized, double-blind, placebo-controlled trial that recru

20 Here we report on a randomized, double-blind, placebo-controlled trial of an oral

21 We performed a randomized, double-blind, placebo-controlled trial in which,

22 We performed a randomized, double-blind, placebo-controlled trial involving

23 e (40 mg lovastatin vs placebo in 30 cases), we performed a randomized, double-blind, placebo-controlled trial of 5 days

24 We performed a randomized, double-blind, placebo-controlled trial of anastro

25 We performed a randomized, double-blind, placebo-controlled trial to determi

26 We yoked anatomical brain magnetic resonance imaging to a randomized, double-blind, placebo-controlled trial (RCT) of a

27 METHODS AND TIME was a randomized, double-blind, placebo-controlled trial comparing

28 The Vitamin D Antenatal Asthma Reduction Trial was a randomized, double-blind, placebo-controlled trial conducted

29 mentation en Vitamines et Mineraux Antioxydants study was a randomized, double-blind, placebo-controlled trial in which p

30 Kidney Disease Antidepressant Sertraline Trial (CAST) was a randomized, double-blind, placebo-controlled trial involving

31 in Myocardial Infarction 50 (TRA2 degrees P-TIMI 50) was a randomized, double-blind, placebo-controlled trial of vorapax

32 ion of Atherothrombotic Ischemic Events-TIMI 50 trial was a randomized, double-blind, placebo-controlled trial of vorapax

33 The Physicians' Health Study II was a randomized, double-blind, placebo-controlled trial testing mu

34 ke in children with overweight and obesity.This study was a randomized, double-blind, placebo-controlled trial.

35 immunological effects of deworming, we conducted a cluster-randomized, double-blind, placebo-controlled trial in Indones

36 This exploratory, randomized, double-blind, placebo-controlled trial assessed a

37 In this first randomized, double-blind, placebo-controlled trial of omalizu

38 In this first randomized, double-blind, placebo-controlled trial, enoxapari

39 al Asthma Reduction Trial (VDAART), a well-conducted large, randomized, double-blind, placebo-controlled trial of vitamin

40 Multicenter, randomized, double-blind, placebo-controlled trial conducted

41 We conducted a multicenter, randomized, double-blind, placebo-controlled trial involving

42 In this prospective, multicenter, randomized, double-blind, placebo-controlled trial, 96 HT rec

43 In a preregistered, randomized, double-blind, placebo-controlled trial, we tested

44 In a prospective, randomized, double-blind, placebo-controlled trial, we enroll

45 no medical history or signs of asthma, were included in the randomized, double-blind, placebo-controlled trial, comprisin

46 This randomized, double-blind, placebo-controlled trial assessed t

47 This randomized, double-blind, placebo-controlled trial recruited

48 In this randomized, double-blind, placebo-controlled trial, 18- to 50

49 In this randomized, double-blind, placebo-controlled trial, we invest

50 METHOD: This 6-week, randomized, double-blind, placebo-controlled trial included p